Moderna Inc (MRNA)
Solvency ratios
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.30 | 1.33 | 1.35 | 1.74 | 2.86 |
Moderna Inc has consistently maintained a strong solvency position over the years, as indicated by its low debt-to-assets, debt-to-capital, and debt-to-equity ratios, all of which are reported as 0.00 from December 31, 2020, to December 31, 2024. These ratios suggest that the company has no significant debt obligations relative to its assets, capital, or equity during the period in question.
Furthermore, Moderna's financial leverage ratio has shown a declining trend from 2.86 on December 31, 2020, to 1.30 on December 31, 2024. This decrease indicates a reduced reliance on debt financing and a more conservative capital structure, which is generally seen as a positive sign of financial stability and strength.
Overall, based on the solvency ratios provided, Moderna Inc appears to have a solid financial foundation with minimal debt burden and effective management of leverage, positioning the company well to weather potential financial challenges and pursue future growth opportunities.
Coverage ratios
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Interest coverage | -149.29 | -102.74 | 324.83 | 738.67 | -77.19 |
The interest coverage ratio measures a company's ability to pay its interest expenses on outstanding debt with its operating income. Looking at the data for Moderna Inc from December 31, 2020, to December 31, 2024, we observe significant fluctuations in the interest coverage ratio.
As of December 31, 2020, the interest coverage ratio was negative at -77.19, indicating that the company's operating income was insufficient to cover its interest expenses. This raises concerns about Moderna's ability to meet its debt obligations solely from its operations.
However, there was a substantial improvement in the ratio by December 31, 2021, reaching 738.67. This suggests that Moderna's operating income was significantly higher compared to its interest expenses, reflecting a healthier financial position and increased ability to service debt.
By December 31, 2022, the interest coverage ratio remained strong at 324.83, indicating continued profitability and the company's capacity to manage its interest payments comfortably.
Yet, there was a notable decline in the ratio by December 31, 2023, dropping to -102.74. A negative interest coverage ratio signifies that the company's operating income was insufficient to cover its interest expenses, posing financial risks and suggesting potential challenges in meeting debt obligations.
Moreover, the ratio further deteriorated by December 31, 2024, reaching -149.29, indicating a continued struggle in managing interest payments with operating income.
Overall, the analysis of Moderna Inc's interest coverage ratio reveals fluctuations in the company's ability to cover interest expenses over the period, highlighting the importance of monitoring financial performance and debt management strategies to ensure long-term financial stability.